Ocular associations of diabetes other than diabetic retinopathy

Diabetes Care

Volumn 31, Issue 9, 2008, Pages 1905-1912

  Jeganathan, V Swetha E ^a,b   Wang, Jie Jin ^a,c   Wong, Tien Yin ^a,c,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^c UNIVERSITY OF SYDNEY   (Australia)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE MEASUREMENT; CATARACT; CATARACT EXTRACTION; CORNEA DISEASE; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; EYE EXAMINATION; EYE MOVEMENT DISORDER; GLAUCOMA; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERTENSION RETINOPATHY; LIPID BLOOD LEVEL; NEOVASCULAR GLAUCOMA; OPTIC NERVE DISEASE; RETINA ARTERY OCCLUSION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK FACTOR; VISUAL IMPAIRMENT; EYE DISEASE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RETINA ARTERY; UNITED STATES;

ARTERIAL OCCLUSIVE DISEASES; CORNEAL DISEASES; DIABETES COMPLICATIONS; DIABETIC RETINOPATHY; EYE DISEASES; GLAUCOMA; HUMANS; RETINAL ARTERY; UNITED STATES;

EID: 56149083218     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0342     Document Type: Review

References (160)

1. Congdon NG, Friedman DS, Lietman T: Important causes of visual impairment in the world today. JAMA 290:2057-2060, 2003
2. Kempen JH, et al: The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 122:552-563, 2004
3. Mohamed Q, Gillies MC, Wong TY: Management of diabetic retinopathy: a systematic review. JAMA 298:902-916,2007
4. Cavallerano JD: A review of non-retinal ocular complications of diabetes melli- tus. J Am Optom Assoc 61:533-543, 1990
5. American Optometric Association: Optometric Clinical Practice Guideline: Care of the Patient with Diabetes Mellitus [article online]. Available from http://www.aoa. org/documents/CPG-3.pdf. Accessed 25 January 2008
6. Stanga PE, Boyd SR, Hamilton AM: Ocular manifestations of diabetes mellitus. Curr Opin Ophthalmol 10:483-489, 1999
7. Rowe NG, et al: Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiol 7:103-114, 2000
8. Hiller R, Sperduto RD, EdererF: Epidemi- ologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am J Epidemiol 124:916-925, 1986
9. Miglior S, et al: Risk factors for cortical, nuclear, posterior subcapsular and mixed cataract: a case-control study. Ophthalmic Epidemiol 1:93-105, 1994
10. Delcourt C, et al: Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study: Pathologies Ocu- laires Liees a l'Age. Am J Epidemiol 151: 497-504, 2000
11. Klein BE, et al: Older-onset diabetes and lens opacities: the Beaver Dam Eye Study. Ophthalmic Epidemiol 2:49-55, 2005
12. SaxenaS, Mitchell P, RochtchinaE: Five- year incidence of cataract in older persons with diabetes and pre-diabetes. Ophthalmic Epidemiol 11:271-277, 2004
13. McCarty CA, et al: Risk factors for age- related maculopathy: the Visual Impairment Project. Arch Ophthalmol 119:1455-1462, 2001
14. Mukesh BN, et al: Development of cataract and associated risk factors: the Visual Impairment Project. Arch Ophthalmol 124: 79 -85, 2006
15. Leske MC, Chylack LT Jr, Wu SY: The Lens Opacities Case-Control Study: risk factors for cataract. Arch Ophthalmol 109:244-251, 1991
16. Hennis A, et al: Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies. Arch Ophthalmol 122:525-530, 2004
17. Foster PJ, et al: Risk factors for nuclear, cortical and posterior subcapsular cataracts in the Chinese population of Singapore: the Tanjong Pagar Survey. Br J Ophthalmol 87:1112-1120, 2003
18. Tsai SY, et al: Epidemiologic study of age-related cataracts among an elderly Chinese population in Shih-Pai, Taiwan. Ophthalmology 110:1089-1095, 2003
19. Nirmalan PK, et al: Risk factors for age related cataract in a rural population of southern India: the Aravind Comprehensive Eye Study. Br J Ophthalmol 88: 989-994, 2004
20. Leske MC, et al: Diabetes, hypertension, and central obesity as cataract risk factors in a black population: the Barbados Eye Study. Ophthalmology 106:35-41, 1999
21. Harding JJ, et al: Diabetes, glaucoma, sex, and cataract: analysis of combined data from two case control studies. Br J Ophthalmol 77:2-6, 1993
22. Bron AJ, et al: The lens in diabetes. Eye 7:260-275, 1993
23. Klein BE, Klein R, Lee KE: Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol 126:782-790, 1998
24. Kato S, et al: Glycemic control and lens transparency in patients with type 1 diabetes mellitus. Am J Ophthalmol 131:301-304, 2001
25. Klein BE, Klein R, Moss SE: Incidence of cataract surgery in the Wisconsin Epide- miologic Study of Diabetic Retinopathy. Am J Ophthalmol 119:295-300, 1995
26. Negahban K, Chern K: Cataracts associated with systemic disorders and syndromes. Curr Opin Ophthalmol 13:419-422, 2002
27. Pirie A: Epidemiological and biochemical studies of cataract and diabetes. Invest Ophthalmol 4:629-637, 1965
28. Murtha T, Cavallerano J: The management of diabetic eye disease in the setting of cataract surgery. Curr Opin Ophthalmol 18:13-18, 2007
29. Hykin PG, et al: Extracapsular cataract extraction in proliferative diabetic retinopathy. Ophthalmology 100:394-399, 1993
30. Chew EY, et al: Results after lens extraction in patients with diabetic retinopa- thy: early treatment diabetic retinopathy study report number 25. Arch Ophthal- mol 117:1600-1606, 1999
31. Cohen SM, et al: Endopthalmitis after pars plana vitrectomy: the Postvitrec- tomy Endopthalmitis Study. Opthalmol- ogy 102:705-712, 1995
32. Kattan HM, et al: Nosocomial en- dopthalmitis survey: current injcidence of infection after intreocular surgery. Ophthalmology 98:227-238, 1991
33. Montan PG, et al: Endopthalmitis after cataract surgery: risk factors relating to technique and events of the operation and patient history. Ophthalmology 105: 2171-2177, 1998
34. Scott IU, Flynn HWJ, Feuer W: Endopthalmitis after secondary intraocular lens implantation: a case-control study. Ophthalmology 102:1925-1931, 1995
35. Doft BH, et al. : Diabetes and postcata- ract extraction endopthalmitis. Curr Opin Opthalmol 13:147-151, 2002
36. Characteristics of patients with nonar- teritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol 114:1366-1374, 1996
37. Flammer J, et al: The impact of ocular blood flow in glaucoma. Prog Ret Eye Res 21:359-393, 2002
38. Piltz-Seymour JR, et al: Optic nerve blood flow is diminished in eyes of primary open-angle glaucoma suspects. Am J Ophthalmol 132:63-69, 2001
39. Hayreh SS, et al: Nonarteritic anterior ischemic optic neuropathy: role of nocturnal arterial hypotension. Arch Oph- thalmol 115:942-945, 1997
40. Arnold AC: Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 23:157-163, 2003
41. Hayreh SS, Podhajsky PA, Zimmerman B: Ipsilateral recurrence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 132:734-742, 2001
42. Ischemic Optic Neuropathy Decompression Trial: twenty-four-month update. Arch Ophthalmol 118:793-798, 2000
43. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful: the Ischemic Optic Neuropathy Decompression Trial Research Group. JAMA 273:625-632, 1995
44. Yoles E, Wheeler LA, Schwartz M: Al- pha2-adrenoreceptor agonists are neu- roprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci40:65-73, 1999
45. Kupersmith MJ, et al: Aspirin reduces the incidence of second eye NAION: a retrospective study. J Neuroophthalmol 17:250-253, 1997
46. Barr CC, Glaser JS, Blankenship G: Acute disc swelling in juvenile diabetes: clinical profile and natural history of 12 cases. Arch Ophthalmol 98:2185-2192, 1980
47. Bandello F, Menchini F: Diabetic papil- lopathy as a risk factor for progression of diabetic retinopathy. Retina 24:183-184, 2004
48. Sato T, et al: Development of bilateral, nonarteritic anterior ischemic optic neuropathy in an eye with diabetic papillopathy. Jpn J Ophthalmol 48:158 -162, 2004
49. Hayreh SS, Zahoruk RM: Anterior isch- emic optic neuropathy. VI. In juvenile diabetics. Ophthalmologica 182:13-28,1981
50. Friedrich Y, et al: Diabetic papillopathy with macular star mimicking clinically significant diabetic macular edema. Retina 21:80 -82, 2001
51. Pavan PR, et al: Optic disc edema injuvenile-onset diabetes. Arch Ophthalmol 98:2193-5219, 1980
52. Al-Haddad CE, Jurdi FA, Bashshur ZF : Intravitreal triamcinolone acetonide for the management of diabetic papillopa- thy. Am J Ophthalmol 137:1151-1153, 2004
53. Eshbaugh CG, et al : Simultaneous, multiple cranial neuropathies in diabetes mellitus. J Neuroophthalmol 15:219-224, 1995
54. Singh NP, et al: Multiple cranial nerve palsies associated with type 2 diabetes mellitus. Singapore Med J 47:712-715, 2006
55. Rush JA: Extraocular muscle palsies in diabetes mellitus. Int Ophthalmol Clin24: 155-159, 1984
56. Watanabe K, et al: Characteristics of cranial nerve palsies in diabetic patients. Diabetes Res ClinPract 10:19-27, 1990
57. Patel SV, et al: Diabetes and hypertension in isolated sixth nerve palsy: a population-based study. Ophthalmology 112: 760-763, 2005
58. Burde RM: Neuro-ophthalmic associations and complications of diabetes mellitus. Am J Ophthalmol 114:498-501, 1992
59. Kahn HA, Milton RC: Revised Framing- ham Eye Study prevalence of glaucoma and diabetic retinopathy. Am J Epidemiol 111:769 -776, 1980
60. Dielemans I, et al: Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population: the Rotterdam Study. Ophthalmology 103:1271-1275, 1996
61. Mitchell P, et al: Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology104:712-718, 1997
62. Hennis A, et al: Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology 110:908 -914, 2003
63. Lin HY, et al: Intraocular pressure measured with a noncontact tonometer in an elderly Chinese population: the Shihpai Eye Study. Arch Ophthalmol 123:381-638, 2005
64. Bernth-Petersen P, Bach E: Epidemio- logic aspects of cataract surgery. III. Frequencies of diabetes and glaucoma in a cataract population. Acta Ophthalmol (Copenh) 61:406 -416, 1983
65. Katz J, Sommer A: Risk factors for primary open angle glaucoma. Am J Prev Med 4:110-114, 1988
66. Reynolds DC: Relative risk factors in chronic open-angle glaucoma: an epide- miological study. Am JOptom Physiol Opt 54:116-120, 1977
67. Morgan RW, Drance SM: Chronic open- angle glaucoma and ocular hypertension: an epidemiological study. Br J Ophthalmol 59:211-215, 1975
68. Wilson MR, et al: Acase-control studyof riskfactors in openangle glaucoma. Arch Ophthalmol 105:1066 -1071, 1987
69. Tielsch JM, et al: Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology 102:48 -53, 1995
70. Vijaya L, et al: Prevalence of open-angle glaucoma in a rural south Indian population. Invest Ophthalmol Vis Sci 46:4461-1167, 2005
71. Kahn HA, Milton RC: Alternative definitions of open-angle glaucoma: effect on prevalence and associations in the Fra- mingham eye study. Arch Ophthalmol 98:2172-2177, 1980
72. Bengtsson B: The prevalence of glaucoma. Br JOphthalmol 65:46 -49, 1981
73. Armaly MF, et al: Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects. Arch Ophthalmol 98:2163-2171, 1980
74. Grunwald JE, et al: Retinal autoregula- tion in open-angle glaucoma. Ophthalmology 91:1690 -1694, 1984
75. Nakamura M, Kanamori A, Negi A: Diabetes mellitus as a risk factor for glaucoma- tous optic neuropathy. Ophthalmologica 219:1-10, 2005
76. Jacobson DR, Murphy RP, Rosenthal AR: The treatment of angle neovascu- larization with panretinal photocoagulation. Ophthalmology 86:1270 -1277, 1979
77. Zeiter JH, Shin DH, Baek NH: Visual field defects in diabetic patients with primary open-angle glaucoma. Am J Oph- thalmol 111:581-584, 1991
78. Mapstone R, Clark CV: Prevalence of diabetes in glaucoma. Br Med J (Clin Res Ed) 291:93-95, 1985
79. Mapstone R, Clark CV: The prevalence of autonomic neuropathy in glaucoma. Trans Ophthalmol Soc UK 104:265-109, 1985
80. Clark CV: Autonomic denervation hy- persensitivity in the primary glaucomas. Eye 3:349-354, 1989
81. Schertzer RM, Wang D, Bartholomew LR: Diabetes mellitus and glaucoma. Int Ophthalmol Clin 38:69 -87, 1998
82. Madsen PH: Experiences in surgical treatment of haemorrhagic glaucoma: a follow-up study. Acta Ophthalmol Suppl 120:88-91, 1973
83. BrownGC, et al : Neovascular glaucoma: etiologic considerations. Ophthalmology 91:315-320, 1984
84. Loffler KU: [Neovascular glaucoma: aetiology, pathogenesis and treatment]. Ophthalmologe 103:1057-1063, 2006 [Article in German]
85. Hohl RD, Barnett DM: Diabetic hemor- rhagic glaucoma. Diabetes 19:944-947, 1970
86. Zirm M: Protein glaucoma-overtaxing of flow mechanisms? Preliminary report. Ophthalmologica 184:155-161, 1982
87. Sivak-Callcott JA, et al: Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology 108:1767-1776, 2001
88. Chen CS, Miller NR: Ocular ischemic syndrome: review of clinical presentations, etiology, investigation, and management. Compr Ophthalmol Update 8:17-28, 2007
89. Mizener JB, Podhajsky P, Hayreh SS: Ocular ischemic syndrome. Ophthalmology 104:859-864, 1997
90. Ino-ue M, et al: Ocular ischemic syndrome in diabetic patients. Jpn JOphthal- mol 43:31-35, 1999
91. Sivalingam A, et al: The ocular ischemic syndrome. II. Mortality and systemic morbidity. Int Ophthalmol 13:187-191, 1989
92. Beneficial effect of carotid endarterec- tomy in symptomatic patients with high- grade carotid stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 325: 445-453, 1991
93. Kawaguchi S, et al: Effect of carotid endarterectomy on chronic ocular ischemic syndrome due to internal carotid artery stenosis. Neurosurgery 48: 328-332, 2001
94. Kawaguchi S, et al: Effect of carotid artery stenting on ocular circulation and chronic ocular ischemic syndrome. Cerebrovasc Dis 22:402-408, 2006
95. Green WR, et al: Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina 1:27-55, 1981
96. Christoffersen NL, Larsen M: Patho- physiology and hemodynamics ofbranch retinal vein occlusion. Ophthalmology 106:2054-2062, 1999
97. Mohamed Q, et al: Interventions for central retinal vein occlusion: an evidence- based systematic review. Ophthalmology 114:507-519, 2007
98. Shahsuvaryan ML, MelkonyanAK: Central retinal vein occlusion risk profile: a case-control study. Eur J Ophthalmol 13: 445-452, 2003
99. Sperduto RD, et al: Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. Ophthalmology 105: 765-771,1998
100. Rath EZ, et al: Risk factors for retinal vein occlusions: a case-control study. Ophthalmology 99:509-514, 1992
101. Mitchell P, W. Smith, Chang A: Prevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye Study. Arch Ophthalmol 114:1243-1247, 1996
102. Hayreh SS, et al: Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 131:61-77, 2001
103. Klein R, et al: The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 98: 133-141, 2000
104. The Eye Disease Case-Control Study Group: Risk factors for central retinal vein occlusion. Arch Ophthalmol 114: 545-554, 1996
105. Wong TY, et al: Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities and Cardiovascular Health studies. Ophthalmology 112:540-547, 2005
106. Pinna A, et al: Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion. Invest Ophthalmol Vis Sci 48: 2747-2752, 2007
107. Natural history and clinical management of central retinal vein occlusion: the Central Vein Occlusion StudyGroup. Arch Ophthalmol 115:486-491, 1997
108. West JA, et al: Panretinal photocoagulation during cataract extraction in eyes with active proliferative diabetic eye disease. Eye 13:170-173, 1999
109. Evaluation of grid pattern photocoagu- lation for macular edema in central vein occlusion: the Central Vein Occlusion Study Group M report. Ophthalmology 102:1425-1433, 1995
110. Hirano Y, et al: Comparative study on efficacy of a combination therapy of tri- amcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion. Ophthalmic Res 39:207-212, 2007
111. Margolis R, Singh RP, Kaiser PK: Branch retinal vein occlusion: clinical findings, natural history, and management. Compr Ophthalmol Update 7:265-276, 2006
112. Manuchehri K, Kirkby G: Vitreous haemorrhage in elderly patients: management and prevention. Drugs Aging 20:655-661, 2003
113. Hawkins WR: Venous occlusive disease review (Letter). Retina 27:514, 2007
114. Funderburk RL, Feinberg EB: Diabetes as a risk factor for retinal neovasculariza- tion in retinal vein occlusion. Ann Ophthalmol 21:65-66, 1989
115. Cugati S, et al: Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts. Ophthalmology 114:520-524, 2007
116. Hayreh SS, Zimmerman MB, Podhajsky P: Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am JOph- thalmol 117:429-441, 1994
117. Lord RS: Transient monocular blindness. AustNZJOphthalmol 18:299-305, 1990
118. Klein R, et al: Retinal emboli and stroke: the Beaver Dam Eye Study. Arch Oph- thalmol 117:1063-1068, 1999
119. Bruno A, et al: Vascular outcome in men with asymptomatic retinal cholesterol emboli: a cohort study. Ann Intern Med 122:249-253, 1995
120. Klein R, et alL Retinal emboli and cardiovascular disease: the Beaver Dam Eye Study. Arch Ophthalmol 121:1446-14451, 2003
121. Wang JJ, et al: Retinal arteriolar emboli and long-term mortality: pooled data analysis from two older populations. Stroke 37:1833-1836, 2006
122. Breen LA: Atherosclerotic carotid disease and the eye. Neurol Clin 9:131-145, 1991
123. Recchia FM, Brown GC: Systemic disorders associated with retinal vascular occlusion. Curr Opin Ophthalmol 11:462-467, 2000
124. Hondeghem K, Blanckaert M, Blanckaert J: Branch retinal artery occlusion in systemic diseases: a case report. Bull Soc Belge Ophtalmol 271:9-15, 1999
125. Klein BE, Klein R, Moss SE: Intraocular pressure in diabetic persons. Ophthalmology 91:1356 -13560, 1984
126. Beatty S, Au Eong KG: Acute occlusion of the retinal arteries: current concepts and recent advances in diagnosis and management. J Accid Emerg Med 17:324 -329, 2000
127. Hayreh SS, Zimmerman B, Kardon RH: Visual improvement with corticosteroid therapy in giant cell arteritis: report of a large study and review of literature. Acta Ophthalmol Scand 80:355-367, 2002
128. Yuzurihara D, Iijima H: Visual outcome in central retinal and branch retinal ar- teryocclusion. Jpn JOphthalmol 48:490 -492, 2004
129. Fujishima H, Tsubota K: Improvement of corneal fluorescein staining in post cataract surgery of diabetic patients by an oral aldose reductase inhibitor, ONO-2235. Br JOphthalmol 86:860-863, 2002
130. Hiraoka M, et al: Factors contributing to corneal complications after vitrectomy in diabetic patients. Jpn JOphthalmol 45:492-495, 2001
131. Brightbill FS, Myers FL, Bresnick GH: Postvitrectomy keratopathy. Am J Oph-thalmol 85:651-655, 1978
132. Tabatabay CA, et al: Reduced number of hemidesmosomes in the corneal epithelium of diabetics with proliferative vit- reoretinopathy. Graefes Arch Clin Exp Ophthalmol 226:389-392, 1988
133. Friedman EA: Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications. Diabetes Care 22 (Suppl. 2):B65-B71, 1999
134. Didenko TN, et al: [Clinical and patho- genetic features of neurotrophic corneal disorders in diabetes]. Vestn Oftalmol 115:7-11, 1999 [Article in Russian]
135. Tavakoli M, et al: Corneal sensitivity is reduced and relates to the severity of neuropathy in patients with diabetes. Diabetes Care 30:1895-1897, 2007
136. Venkatramani J, Mitchell P: Ocular and systemic causes of retinopathy in patients without diabetes mellitus. BMJ 328:625-629, 2004
137. Vidaurri JS, et al: Association between drusen and some of the risk factors for coronary artery disease. Ophthalmologica 188:243-247, 1984
138. Algvere P, et al: Retinal microangiopathy and pigment epithelial lesions in subjects with normal, borderline, and decreased oral glucose tolerance. Br J Ophthalmol 69:416 -419, 1985
139. Kahn HA, et al: The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol 106:17-32, 1977
140. Hyman LG, et al: Senile macular degeneration: a case-control study. Am J Epidemiol 118:213-227, 1983
141. Blumenkranz MS, et al: Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 93:552-558, 1986
142. Maltzman BA, Mulvihill MN, Green- baum A: Senile macular degeneration and risk factors: a case-control study. Ann Ophthalmol 11:1197-1201, 1979
143. Voutilainen-Kaunisto RM, et al: Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects: a 10-year follow-up on evolution, risk factors, and prognostic significance. Diabetes Care 23:1672-1678, 2000
144. Hageman GS, et al: An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE- Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20:705-732, 2001
145. Seddon JM, et al: Association between C-reactive protein and age-related mac- ular degeneration. JAMA 291:704-710, 2004
146. Hammer M, et al: Ocular fundus auto- fluorescence observations at different wavelengths in patients with age-related macular degeneration and diabetic reti- nopathy. Graefes Arch Clin Exp Ophthal- mol 246:105-114, 2008
147. Wong TY, G. Liew, Mitchell P: Clinical update: new treatments for age-related macular degeneration. Lancet 370:204- 206, 2007
148. Rosenfeld PJ, et al: Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419-1431, 2006
149. Gragoudas ES, et al: Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351:2805-2816, 2004
150. Wong TY, et al: Retinopathy and risk of congestive heart failure. JAMA 293:63-69, 2005
151. Wong TY, Mitchell P: Hypertensive ret- inopathy signs are independent predictors of cardiovascular diseases (Letter). Br Med J331:73, 2005
152. Wong TY, et al: Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet 358:1134-1140, 2001
153. Wong TY, et al: Retinal arteriolar narrowing and risk of coronary heart disease in men and women: the Atherosclerosis Risk in Communities Study. JAMA 287:1153-1159, 2002
154. Wong TY, Mitchell P: Hypertensive ret- inopathy. N Engl J Med 351:2310 -2317, 2004
155. Archer DB, Gardiner TA: Ionizing radiation and the retina. Curr Opin Ophthal mol 5:59 -65, 1994
156. Gupta A, et al: Radiation retinopathy: case report and review (Letter). BMC Ophthalmol 7:6, 2007
157. Viebahn M, Barricks ME, Osterloh MD: Synergism between diabetic and radiation retinopathy: case report and review. Br JOphthalmol 75:629 -632, 1991
158. Graham CE, et al: Laser photocoagula- tion: ocular research and therapy in diabetic retinopathy. Adv Exp Med Biol 572:195-200, 2006
159. Kramer M, Lynn W, Lightman S: HIV/ AIDS and the eye. Hosp Med 64:421-424,2003
160. Hoerle S, Kroll P: Evidence-based therapy of diabetic retinopathy. Ophthalmo- logica 221:132-141, 2007